Background glaucoma Shape Background glaucoma Shape Background glaucoma Shape
Grants > T61 is a New Protein That Supports Retinal Axon Outgrowth and Regeneration Updated On: Ene. 23, 2025
National Glaucoma Research Grant

T61 is a New Protein That Supports Retinal Axon Outgrowth and Regeneration

Principal Investigator

Philippe Monnier, PhD

Toronto Western Hospital

Toronto, Ontario, Canada

About the Research Project

Program

National Glaucoma Research

Award Type

Standard

Award Amount

$68,852

Active Dates

April 01, 2004 - March 31, 2006

Grant ID

G2004035

Summary

Glaucoma can be viewed as a neurodegenerative disease in which retinal nerve cells degenerate. These nerve cells are responsible for carrying signals from the retina to the brain, and their loss results in blindness. A novel treatment for glaucoma would be to promote the regeneration of lost retinal nerve cells. Dr. Monnier has identified a protein (T61) that supports nerve growth, and its characterization represents an important step toward a molecular understanding of the environment that retinal nerve cells need in order to regenerate. Dr. Monnier believes that the lack of regeneration is due to the inhibitory factors in the environment of retinal nerve cells. He plans to first clone this protein, and then to perform a biochemical characterization and study its interaction with other proteins. He hopes to confirm the hypothesis that T61 supports retina nerve cell regeneration by showing that T61 allows nerve cell growth even in the presence of inhibitory factors that hamper regeneration. This is a long-term study that could have important consequences for the development of new treatments for glaucoma.